NCM is a partner of PURA and this may be more insight into the new extraction spin-off coming from GRCO and PURA. This looks like extraction TESTING Services as a new line of business for Quality Control of Products:
PASO ROBLES, California, February 6, 2018 /PRNewswire/ --
NCM Biotech (NCM) and Greenbelt Resources Corporation (GRCO) (Greenbelt) today announced they are entering into a Letter of Intent (LOI) to jointly develop and operate a cannabis extraction testing service with facilities in California and Oregon. When operational, the facilities will serve the global medical cannabis market. NCM Biotech has a process, patented in 2016, for extracting cannabinoids from the cannabis plant.
NCM Biotech is the for-profit outgrowth of Natures Comfort Meds, a not-for-profit research organization dedicated to discovering and developing solutions to medical issues through the use of the cannabis plant and its oils. With a scientific advisory team that includes, Dr. John Gaitanis, Pediatric Neurologist at Tufts Medical Center/Floating Hospital for Children and Dr. Lloyd Saberski, Anesthesiologist/Pain Management Specialist practicing at Yale New Haven Medical Center, NCM maintains research partnerships for live genomics testing with Brown University and Beech Tree Labs.
NCM recently completed successful tests of Greenbelt's bioethanol for use as a solvent during the extraction process. Greenbelt produced the bioethanol from brewery waste collected in its hometown of Paso Robles, California. Brewery waste, along with other local waste-based feedstocks, is targeted for use in Greenbelt's Commercial Scale Feedstock Testing Facility, currently under development and expected to be in production by the end of 2018.
The LOI expresses the intention of the two companies to combine their respective resources and build and operate extraction testing services based in Oregon and in Greenbelt's facility in California.
